Invention Application
- Patent Title: USE OF ANGIOPOIETINS IN PROMOTING BLOOD COAGULATION AND IN THE TREATMENT OF BLOOD COAGULATION DISORDERS
- Patent Title (中): 使用血管生成促进血液凝结和治疗血液凝结异常
-
Application No.: PCT/US2016/060527Application Date: 2016-11-04
-
Publication No.: WO2017079556A1Publication Date: 2017-05-11
- Inventor: DALY, Christopher , DAVIS, Samuel
- Applicant: REGENERON PHARMACEUTICALS, INC.
- Applicant Address: 777 Old Saw Mill River Road Tarrytown, New York 10591-6707 US
- Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee: REGENERON PHARMACEUTICALS, INC.
- Current Assignee Address: 777 Old Saw Mill River Road Tarrytown, New York 10591-6707 US
- Agency: TERMES, Lance et al.
- Priority: US62/252,217 20151106
- Main IPC: A61K38/18
- IPC: A61K38/18 ; A61P7/04
Abstract:
The present invention provides methods for promoting blood coagulation and/or treating blood coagulation disorders in a subject in need thereof. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising an angiopoietin protein or a modified angiopoietin protein molecule such as AngF1 -Fc-F1 or AngF2-Fc-F2.
Information query
IPC分类:
